Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


COVID-19: Daily Top 10 Papers


  Valvular Heart Disease

  Free Subscription


14.06.2021

1 Ann Thorac Cardiovasc Surg
3 Eur Heart J
7 Int J Cardiol
5 J Card Surg


  Retrieve available abstracts of this week’s articles:
HTML format
 
 
Single Articles


    Ann Thorac Cardiovasc Surg

  1. HUANG ST, Xu N, Sun KP, Chen Q, et al
    Effect of Treprostinil on the Early Postoperative Prognosis of Patients with Severe Left Heart Valvular Disease Combined with Severe Pulmonary Hypertension.
    Ann Thorac Cardiovasc Surg. 2020 Jun 3. doi: 10.5761/atcs.oa.20-00003.
    PubMed         Abstract available


    Eur Heart J

  2. CALIGIURI G, Franck G
    Hitting the right channels to spread a 'no-restenosis' message to vascular wall cells.
    Eur Heart J. 2021;42:1786-1788.
    PubMed        

  3. KASKI JP
    Childhood-onset hypertrophic cardiomyopathy research coming of age.
    Eur Heart J. 2021;42:1997-1999.
    PubMed        

  4. MARSTON NA, Han L, Olivotto I, Day SM, et al
    Clinical characteristics and outcomes in childhood-onset hypertrophic cardiomyopathy.
    Eur Heart J. 2021;42:1988-1996.
    PubMed         Abstract available


    Int J Cardiol

  5. VESELKA J, Faber L, Liebregts M, Cooper R, et al
    Alcohol dose in septal ablation for hypertrophic obstructive cardiomyopathy.
    Int J Cardiol. 2021;333:127-132.
    PubMed         Abstract available

  6. RODRIGUEZ-GABELLA T, Zimarino M, Barbanti M, Testa L, et al
    Sex based analysis of the impact of red blood cell transfusion and vascular or bleeding complications related to TAVI - The TRITAVI-Women Study.
    Int J Cardiol. 2021;333:69-76.
    PubMed         Abstract available

  7. NARANG R, Saxena A, Ramakrishnan S, Gupta SK, et al
    An evidence-based scoring system to diagnose acute rheumatic fever with carditis in children.
    Int J Cardiol. 2021;333:146-151.
    PubMed         Abstract available

  8. MARTIN M, Junco-Vicente A, Rodriguez I
    Bicuspid aortopathy in adolescents: Another piece of the puzzle.
    Int J Cardiol. 2021;333:94-95.
    PubMed        

  9. PELLICCIA F, Pasceri V
    The less-is-better effect: The case of alcohol dose in septal ablation for hypertrophic cardiomyopathy.
    Int J Cardiol. 2021;333:143-144.
    PubMed        

  10. WANG TKM, Kwon DH, Abou-Hassan O, Chetrit M, et al
    Strain evaluation for mitral annular disjunction by echocardiography and magnetic resonance imaging: A case-control study.
    Int J Cardiol. 2021;334:154-156.
    PubMed         Abstract available

  11. KAMPAKTSIS PN, Tzoumas A
    LV apical aneurysm in HCM: Implant ICD and anticoagulate?: Editorial comment on: "Prognostic role of left ventricular apical aneurysm in hypertrophic cardiomyopathy: A systematic review and meta-analysis."
    Int J Cardiol. 2021;334:86-87.
    PubMed        


    J Card Surg

  12. KITAHARA H, Najjar S, Ahmed S, Lam P, et al
    Edge-to-edge mitral repair for iatrogenic chordal rupture related to Impella 5.0.
    J Card Surg. 2021;36:2541-2542.
    PubMed         Abstract available

  13. GARRETT HE JR
    Intraoperative repair of mitral paravalvular leak with Amplatzer plug.
    J Card Surg. 2021;36:2423-2425.
    PubMed         Abstract available

  14. MARSICO R, Zakkar M, Bruno VD, Mansour S, et al
    The impact of patient-prosthesis mismatch on early and long-term survival after aortic replacement with the Edwards Perimount valve: A propensity score-matched analysis.
    J Card Surg. 2021;36:2269-2276.
    PubMed         Abstract available

  15. BELLUSCHI I, Buzzatti N, Denti P, Romano V, et al
    First-in-man Valve-in-Valve with the new balloon-expandable Myval transcatheter heart valve in a failed sutureless Perceval bioprosthesis.
    J Card Surg. 2021;36:2546-2548.
    PubMed         Abstract available

  16. GALEA N, Pambianchi G, Cilia F, Mancuso G, et al
    Giant caseous mitral annular calcification mimicking ventricular pseudoaneurysm.
    J Card Surg. 2021;36:2539-2540.
    PubMed         Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Valvular Heart Disease is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: